Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

ISIS ANTI-WART COMPOUND TO ENTER CLINIC

March 5, 1992

CEPHALON PATENT FOR ALS TREATMENT

March 5, 1992

COLUMBIA, INSITE EXCHANGE TECHNOLOGY

March 5, 1992

NEUPOGEN SALES BEGIN IN CANADA

March 5, 1992

COMPANIES CRITICIZE SENATOR'S DATA

March 4, 1992

GENZYME LAUNCHES ANOTHER NEOZYME

March 4, 1992

NEW GENENTECH, ROCHE COLLABORATIONS

March 4, 1992

KESSLER OPPOSES ORPHAN DRUG ACT CHANGES

March 4, 1992

GLYCOMED RIGHTS TO DRUG DELIVERY METHOD

March 4, 1992

GI AND AHP TARGET SMALL MOLECULES

March 4, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...